CVS Health 8-K
PositiveEarningsGuidance raised
Health Care Benefits margin recovery and stronger Pharmacy & Consumer Wellness results drive higher EPS and cash flow guidance.
Filed 2026-08-05 06:32 ET
- 2.02 Results of Operations
- 9.01 Financial Statements and Exhibits
Summary
Q2 2026 results with raised FY2026 guidance. Revenue increased 7.3% Y/Y, and adjusted operating income rose across all segments. CVS raised its full-year GAAP and adjusted EPS and operating cash flow outlook, citing stronger Health Care Benefits and Pharmacy & Consumer Wellness results, while noting elevated cost trends and potential macro headwinds.
Key Figures
| Metric | Q2 2026 | Q2 2025 | Y/Y |
|---|---|---|---|
| Revenue | $106.1B | $98.9B | 7.3% |
| Operating income | $4.70B | $2.38B | 97.5% |
| Adjusted operating income, non-GAAP | $5.16B | $3.81B | 35.4% |
| Net income | $3.00B | $1.01B | 196% |
| Diluted EPS, GAAP | $2.31 | $0.80 | 189% |
| Adjusted EPS, non-GAAP | $2.58 | $1.81 | 42.5% |
- Operating income growth also reflected the absence of $833M in prior-year legacy litigation charges. Health Care Benefits’ medical benefit ratio fell 250 bp to 87.4%, driven by improved Government business performance and the absence of a prior-year premium deficiency reserve.
- H1 operating cash flow was $10.6B vs $6.45B, up 64.2%. At 6/30/2026, cash was $11.3B and total debt carrying value was $61.4B, vs $8.45B and $64.6B at 12/31/2025.
- Health Services adjusted operating income rose 10.0%; Pharmacy & Consumer Wellness adjusted operating income rose 10.2%, with prescriptions filled up 4.3%.
Guidance
| Metric | Period | Guidance | Prior | Direction |
|---|---|---|---|---|
| Revenue | FY2026 | At least $414B | — | — |
| Diluted EPS, GAAP | FY2026 | $6.84-$7.04 | $6.24-$6.44 | Raised |
| Adjusted EPS, non-GAAP | FY2026 | $7.90-$8.10 | $7.30-$7.50 | Raised |
| Cash flow from operations | FY2026 | At least $11.5B | At least $9.5B | Raised |
Investor Takeaways
- Track results against the higher FY2026 ranges; CVS cited continued elevated cost trends and potential macro headwinds for the rest of the year.
- Health Care Benefits’ margin recovery and performance in Pharmacy & Consumer Wellness are key drivers behind the raised outlook.
The summary is written by an AI model reading the filing.
Model 005 · prompt 01d34d48e3